medRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,471 Articles (22,855 medRxiv, 8,616 bioRxiv)

Most recent first Previous |  Page 723: Articles 7221-7230  | Next

Urban birds' flight responses were unaffected by the COVID-19 shutdowns
Mikula, P., Bulla, M., Blumstein, D., Benedetti, Y., Floigl, K., Jokimaki, J., Kaisanlahti-Jokimaki, M.-L., Marko, G., Morelli, F., Moller, A. P., Siretckaia, A., Szakony, S., Weston, M., Zeid, F. A., Tryjanowski, P., Albrecht, T.
10.1101/2022.07.15.500232 — Posted: 2022-07-16
Lasting alterations in monocyte and dendritic cell subsets in individuals after hospitalization for COVID-19
Hopkins, F. R., Govender, M., Svanberg, C., Nordgren, J., Waller, H., Nilsdotter-Augustinsson, A., Henningsson, A. J., Hagbom, M., Sjowall, J., Nystrom, S., Larsson, M.
10.1101/2022.07.15.500185 — Posted: 2022-07-15
Pangenome analysis of SARS-CoV2 strains to Identify Potential vaccine targets by Reverse Vaccinology
Tariq, M. H., Amir, A., Irshad, H.
10.1101/2022.07.15.500170 — Posted: 2022-07-15
Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2
Ragonnet-Cronin, M., Nutalai, R., Huo, J., Dijokaite-Guraliuc, A., Das, R., Tuekprakhon, A., Supasa, P., Liu, C., Selvaraj, M., Groves, N., Hartman, H., Ellaby, N., Sutton, J. M., Bahar, M. W., Zhou, D., Fry, E., Ren, J., Brown, C., Klenerman, P., Dunachie, S. J., Mongkolsapaya, J., Hopkins, S., Chand, M., Stuart, D. I., Screaton, G. R., Rokadiya, S.
10.1101/2022.07.14.500063 — Posted: 2022-07-15
Neutralization sensitivity of Omicron BA.2.75 to therapeutic monoclonal antibodies
Yamasoba, D., Kimura, I., Kosugi, Y., Uriu, K., Fujita, S., Ito, J., Sato, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium
10.1101/2022.07.14.500041 — Posted: 2022-07-15
Vitamin C is an efficient natural product for prevention of SARS-CoV-2 infection by targeting ACE2 in both cell and in vivo mouse models
Zuo, Y., Zheng, Z., Huang, Y., He, J., Zang, L., Ren, T., Cao, X., Miao, Y., Yuan, Y., Liu, Y., Ma, F., Tian, S., Dai, J., Ding, Q., Zheng, H.
10.1101/2022.07.14.499651 — Posted: 2022-07-15
A zebrafish model of COVID-19-associated cytokine storm syndrome reveals that the Spike protein signals via TLR2
Tyrkalska, S. D., Martinez-Lopez, A., Pedoto, A., Candel, S., Cayuela, M. L., Mulero, V.
10.1101/2022.07.14.500031 — Posted: 2022-07-15
Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine
Leekha, A., Saeedi, A., Sefat, S. R., Kumar, M., Paniagua, M. M., Damian, A., Kulkarni, R., Rezvan, A., Mosoumi, S., Liu, X., Cooper, L. J. N., Sebastian, M., Hurst, B. L., Varadarajan, N.
10.1101/2022.07.14.500068 — Posted: 2022-07-15
SARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1
Richardson, S., Motlou, T., van der Mescht, M., Lambson, B., Everatt, J., Amoako, D., Van Gottberg, A., Wolter, N., de Beer, Z., Roma de Villiers, T., Bodenstein, A., van den Berg, G., Rossouw, T. M., Boswell, M., Ueckermann, V., Bhiman, J., Moore, P.
10.1101/2022.07.14.500039 — Posted: 2022-07-15
Fc effector activity and neutralization against SARS-CoV-2 BA.4 is compromised in convalescent sera, regardless of the infecting variant
Richardson, S., Kgagudi, P., Manamela, N. P., Kaldine, H., Venter, E., Pillay, T., Lambson, B. E., van der Mescht, M., Hermanus, T., de Beer, Z., de Villier, T., Bodenstein, A., van den Berg, G., du Pisanie, M., Burgers, W., Ntusi, N. A. B., Ueckermann, V., Rossouw, T., Boswell, M., Moore, P.
10.1101/2022.07.14.500042 — Posted: 2022-07-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.